Xbox owners won’t need to wait much longer to dive into HoYoverse’s urban fantasy action-RPG. The developer hosted a ...

Patrick Reilly, Eldin Hasic and Nikolas Spilson of Faegre Drinker discuss the European Union's new product liability ...

The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...

A new kind of vaccine is changing how people think about preventing breast cancer. Not just any breast cancer—this one ...

Officials met Hamas three times, breaking with a policy against contacting a group the U.S. considers a terrorist ...

A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously ...

Marvel Rivals is bringing some changes to competitive play with the Season 2 update. Here’s everything you need to know ahead ...

On April 2, 2025, the U.S. Army xTech Program launched xTechOverwatch to advance military capabilities in autonomous air and ...

Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a ...

As developers continue to search for better amyotrophic lateral sclerosis (ALS) therapies, Neurosense Therapeutics Ltd. turned up some hopeful findings from its phase IIb Paradigm trial with PrimeC.

A bridge connecting Pine Island and Matlacha had been one lane since late last year. FDOT announced on April 4 it was open to ...

Opus Genetics (IRD) announced one-month clinical data from the first pediatric patient treated with its investigational gene therapy, ...